C07D 209/54
Spiro-condensed
C07D209/54 (Spiro-condensed) appears on 220 US grants and 232 published applications in this corpus.
Search patents in C07D- Granted patents
- 220
- Published applications
- 232
- Assignees
- 134
- Inventors
- 735
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 5 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 8 | 0 |
| 2002 | 4 | 5 |
| 2003 | 2 | 6 |
| 2004 | 1 | 8 |
| 2005 | 10 | 9 |
| 2006 | 5 | 8 |
| 2007 | 3 | 12 |
| 2008 | 2 | 6 |
| 2009 | 5 | 13 |
| 2010 | 10 | 15 |
| 2011 | 11 | 14 |
| 2012 | 8 | 10 |
| 2013 | 11 | 7 |
| 2014 | 10 | 13 |
| 2015 | 13 | 7 |
| 2016 | 8 | 8 |
| 2017 | 6 | 5 |
| 2018 | 6 | 11 |
| 2019 | 7 | 11 |
| 2020 | 7 | 9 |
| 2021 | 11 | 12 |
| 2022 | 6 | 10 |
| 2023 | 3 | 12 |
| 2024 | 5 | 5 |
| 2025 | 5 | 9 |
| 2026 | 4 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Biphenyl and phenylpyridine compounds16 Jun 2026US 12,655,105 B2Pfizer Inc.
- HDAC6 inhibitors and uses thereof16 Jun 2026US 12,655,106 B2Eikonizo Therapeutics, Inc.
- HDAC6 inhibitors and uses thereof20 Jan 2026US 12,528,767 B2Eikonizo Therapeutics, Inc.
- Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists23 Dec 2025US 12,503,475 B2Centessa Pharmaceuticals (UK) Limited
- Total syntheses of portimine a and analogues thereof as small molecule modulators of nmd320 Aug 2026US 2026/0242390 A1The Scripps Research Institute
- Gpr17 modulators and uses thereof9 Jul 2026US 2026/0193252 A1Myrobalan Therapeutics, Inc.
- Hdac6 inhibitors and uses thereof18 Jun 2026US 2026/0167604 A1Eikonizo Therapeutics, Inc.
- Beta-lactamase inhibitor intermediate and preparation method therefor18 Jun 2026US 2026/0167640 A1Evopoint Biosciences Co., Ltd.
- Heterocyclic ring-substituted aromatic compound, preparation method therefor, and use thereof12 Feb 2026US 2026/0042734 A1Shanghai Henlius Biologics Co., Ltd.
Most cited
By later US patents
- Modified carbocyanine dyes and their conjugates131US 6,977,305 B2Molecular Probes, Inc. · 2005
- Modified carbocyanine dyes and their conjugates105US 6,974,873 B2Molecular Probes, Inc. · 2005
- Substituted 1-H-3-aryl-pyrrolidine-2,4-dione derivatives102US 5,462,913 ABayer Aktiengesellschaft · 1995
- Dialkyl-1-H-3-(2,4-dimethylphenyl)-pyrrolidine-2,4-diones, their preparation and their use89US 5,504,057 ABayer Aktiengesellschaft · 1996
- Alkoxy-alkyl-substituted 1H-3-aryl-pyrrolidine-2, 4-diones used as herbicicides and pesticides84US 5,830,826 ABayer Aktiengesellschaft · 1998